A coronavirus vaccine that can be swallowed like a pill and administered at home could begin clinical trials in the near future after its developers reported promising preliminary data.
The trailblazing drug, called Oravax, is being developed by Israeli-American Oramed Pharmaceuticals and India-based Premas Biotech. The two companies have teamed up to create Oravax Medical Inc., which hopes to combine Oramed’s oral delivery technology with Premas’ vaccine expertise to create a new method of inoculation against Covid-19.
Continue reading https://on.rt.com/b4ab